Search | Médecins Sans Frontières Access Campaign

46 results found

A member of MSF’s mobile vaccination team prepares a dose of COVID-19 vaccine.

Press release |

23 August 2021

Following full FDA approval, Pfizer and BioNTech must urgently share COVID-19 vaccine know-how to increase global production and supply

Sharing mRNA vaccine technology with manufacturers in low- and middle-income countries could offer sustainable, equitable access to COVID-19 vaccines

Tags COVID-19 coronavirus vaccines access to medicines United States of America

The pneumonia vaccine from GSK used for vaccination in refugee camps in Greek islands was made available at a special reduced price of US$9 while its retail price is $168 in Greece.

Press release |

29 January 2020

Global vaccines community must urgently support rollout of new more affordable pneumonia vaccine

Global vaccines community must do everything it can to help introduce the new, more affordable pneumonia vaccine in all countries, especially middle-income countries

Tags Vaccines pneumococcal disease pneumococcal conjugate vaccine access to medicines Gavi, the Vaccine AllianceGlaxoSmithKlinePfizerSerum Institute of India

MSF protests at Wall Street after J&J announces 2019 sales increase

Press release |

22 January 2020

As J&J release earnings, MSF protests price of lifesaving TB drug

MSF protested in front of the New York Stock Exchange in New York today, demanding the pharmaceutical corporation Johnson & Johnson make the tuberculosis drug bedaquiline available for all people with drug-resistant TB or no more than ...

Tags Tuberculosis drug-resistant TBtuberculosis bedaquiline access to medicines Johnson & Johnson

Press release |

10 October 2019

MSF launches global campaign urging Johnson & Johnson to reduce price of life-saving TB drug

Médecins Sans Frontières (MSF) launched a global campaign today calling on pharmaceutical corporation Johnson & Johnson (J&J) to lower the price of its anti-tuberculosis medicine bedaquiline to no more than US$1

Tags Tuberculosis tuberculosis bedaquiline access to medicines Johnson & Johnson J&J Can you hear us?

Bonaventure Ndjekpe, 14, is being kept under surveillance at Paoua Hospital, northwestern Central African Republic, supported by MSF. He would have been bitten on the heel by a snake on Christmas Eve, but there is no sign of blood poisoning. 2018.

Press release |

23 May 2019

MSF welcomes release of long-awaited WHO strategy to tackle snakebite

Tags Tropical & neglected diseases snakebite access to medicines World Health Organization

Pharmacy at Batangafo hospital, Central African Republic 2013.

Press release |

26 October 2018

Rapid shift from global to national purchase of TB drugs increases risk of stockouts and use of drugs of unknown quality

Tags Tuberculosis drug-resistant TB stock outWHO pre-qualification Union Conference on Lung HealthThe Global Drug Facility Netherlands

MSF TB-MDR patients and Green House photos in Mathare.

Press release |

27 July 2018

Update on contentious negotiations for the UN High-level Meeting on Tuberculosis

South Africa breaks the ‘silence’ period and negotiations are re-opened

Tags Tuberculosis tuberculosis access to medicines World Health Organization

Civil society demonstration against IP provisions in RCEP that can block access to affordable medicines. Outside Ministry of Commerce, Udyog Bhawan, New Delhi

Press release |

20 July 2018

ASEAN and India urged not to trade away people’s lives in trade agreement

RCEP trade deal could cut medicines lifeline for people in developing countries

Tags Intellectual property and trade hepatitis Ctuberculosis data exclusivitygeneric medicinesRegional Comprehensive Economic Partnership (RCEP)

A woman dances during a Stop Stock Outs Project activist meeting in Soshanguve, a township outside of Pretoria on April 16, 2015. As a grassroots project, SSP regularly organizes training for people living with HIV in order to equip them on the know how to monitor and report drug shortages.

Press release |

31 May 2018

South Africa takes landmark step for access to medicines

Tags Intellectual property and trade drug-resistant TBtuberculosis access to medicines South Africa

Drug-resistant patient showing daily drug dose

Press release |

03 August 2017

Congress fails to boost treatment for neglected diseases

Tags Intellectual property and tradeResearch and development neglected diseases access to medicinesFDA priority review voucherinnovation

Press release |

21 July 2017

RCEP negotiators must fix the damaging provisions that remain a threat to public health

As negotiators for the Regional Comprehensive Economic Partnership (RCEP) trade agreement meet for another round of negotiations in Hyderabad next week, networks of people living with HIV/AIDS from different parts of the country ...

Tags Intellectual property and trade data exclusivitygeneric medicinesintellectual property & tradeRegional Comprehensive Economic Partnership (RCEP) India

Activists from Doctors Without Borders protest vaccine pricing policies in front of the Pfizer World Headquarters in New York NY, Thursday, April 22, 2015. Pfizer refuses to publish the price of the pnuemococcal vaccine, preventing developing countries from negotiating a fair price for the drug.

Press release |

27 June 2017

Proposed executive order puts pharma interests over people’s lives

Tags Intellectual property and trade access to medicinesintellectual property & trade

Press release |

26 June 2017

MSF urges India’s Modi to remain committed to affordable medicines during White House meeting

Tags Intellectual property and trade access to medicinesgeneric medicines #HandsOffOurMeds India

Press release |

07 June 2017

US Congressional Committee advances legislation that fails to fix FDA PRV program for neglected diseases

Tags Research and development neglected diseases access to medicinesFDA priority review voucherinnovation

Nearly 2,000 People Living With HIV along with MSF & other civil society organisations rallied in the streets of New Delhi at the start of the EU-India summit. They warned that harmful provisions in a trade deal being negotiated between the EU and India could severely hinder access to affordable medicine for people in developing countries.

Press release |

22 March 2017

India–EFTA trade talks may make medicines more expensive

Tags Intellectual property and trade access to medicinesgeneric medicinesintellectual property & trade European Free Trade Association #HandsOffOurMeds India

Treatment of a Kala azar-HIV co-infected patient lasts for almost a month. The duration of long admission impacts the individual and their families, often taking them away from their livelihoods or necessitating a caretaker’s presence. Pictured here is a patient with her daughter in MSF’s Kala azar-HIV ward in Patna, Bihar.

Press release |

02 March 2017

US Lawmakers fail to fix flawed PRV program intended to promote new medicines for neglected diseases

Tags Research and development neglected diseases access to medicinesFDA priority review voucherinnovation United States of America

Press release |

23 February 2017

MSF calls on Japan and South Korea to drop the harmful RCEP measures

Tags Intellectual property and trade access to medicinesdata exclusivitygeneric medicinesintellectual property & tradeRegional Comprehensive Economic Partnership (RCEP) Japan

At the height of the crisis in Yida camp last summer, high mortality rates were reported among young children admitted to MSF’s hospital with respiratory tract infections, such as pneumonia, one of the leading causes of death. 2013 refugee crisis in South Sudan.

Press release |

07 February 2017

Global day of action against Roche’s inhumanity #RocheGreedKills

Tags Intellectual property and trade access to medicines Roche Fix the Patent Laws Campaign South Africa

MSF treats more than 200,000 people worldwide for HIV and 97 percent of the antiretrovirals are quality, affordable generics from India. Here, an MSF doctor in Kenya consults one MSF’s thousands of HIV+ patients under treatment.

Press release |

14 October 2016

In lead-up to RCEP trade deal negotiations in China, MSF urges countries not to trade away access to medicines

As negotiators for the Regional Comprehensive Economic Partnership (RCEP) trade agreement prepare to meet in Tianjin, China, from 17-21 October, Médecins Sans Frontières (MSF)/Doctors Without Borders urges the 16 negotiating countries ...

Tags Intellectual property and trade access to medicinesdata exclusivityintellectual property & tradeRegional Comprehensive Economic Partnership (RCEP)UN High Level Panel on Access to Medicines

A nurse dispensing TB medication inside Colony 3 TB prison.

Press release |

14 September 2016

As UN General Assembly starts, MSF urges governments to set medical research policies that align with people’s health needs

Tags Research and development access to medicinesCEWGinnovationresearch and development (R&D)

Date

Primary topics

Types of content

Products

Diseases

General Terms

Geography

Campaigns

Institutions & Events

Report series

Miscellaneous

Following full FDA approval, Pfizer and BioNTech must urgently share COVID-19 vaccine know-how to increase global production and supply

Global vaccines community must urgently support rollout of new more affordable pneumonia vaccine

As J&J release earnings, MSF protests price of lifesaving TB drug

MSF launches global campaign urging Johnson & Johnson to reduce price of life-saving TB drug

MSF welcomes release of long-awaited WHO strategy to tackle snakebite

Rapid shift from global to national purchase of TB drugs increases risk of stockouts and use of drugs of unknown quality

Update on contentious negotiations for the UN High-level Meeting on Tuberculosis

ASEAN and India urged not to trade away people’s lives in trade agreement

South Africa takes landmark step for access to medicines

Congress fails to boost treatment for neglected diseases

RCEP negotiators must fix the damaging provisions that remain a threat to public health

Proposed executive order puts pharma interests over people’s lives

MSF urges India’s Modi to remain committed to affordable medicines during White House meeting

US Congressional Committee advances legislation that fails to fix FDA PRV program for neglected diseases

India–EFTA trade talks may make medicines more expensive

US Lawmakers fail to fix flawed PRV program intended to promote new medicines for neglected diseases

MSF calls on Japan and South Korea to drop the harmful RCEP measures

Global day of action against Roche’s inhumanity #RocheGreedKills

In lead-up to RCEP trade deal negotiations in China, MSF urges countries not to trade away access to medicines

As UN General Assembly starts, MSF urges governments to set medical research policies that align with people’s health needs